Home ›
Trademark Categories ›
Science & Technology Services ›
2014 ›
TA ›
TAKEDA ONCOLOGY
Trademark search for:
TAKEDA ONCOLOGY
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-12-10 — Application filed
2014-12-13 — Application filed
2014-12-15 — Application filed
2014-12-16 — Notice of design search code e-mailed
2015-03-24 — Assigned to examiner
2015-03-31 — Final disposition recorded
2015-03-31 — Final disposition recorded
2015-03-31 — Final disposition recorded
2015-04-08 — Office action issued
2015-04-08 — Correspondence received in law office
2015-04-09 — Teas/email correspondence entered
2015-04-29 — Approved for pub - principal register
2015-05-26 — Assigned to lie
2015-05-26 — Law office publication review completed
2015-06-10 — Notification of notice of publication e-mailed
2015-06-30 — Published for opposition
2015-06-30 — Official gazette publication confirmation e-mailed
2015-08-25 — Noa e-mailed - sou required from applicant
2016-01-21 — Sou teas extension received
2016-01-21 — Sou extension 1 filed
2016-01-21 — Sou extension 1 granted
2016-01-23 — Notice of approval of extension request e-mailed
2016-08-08 — Sou teas extension received
2016-08-08 — Sou extension 2 filed
2016-08-31 — Case assigned to intent to use paralegal
2016-09-02 — Sou extension 2 granted
2016-09-03 — Notice of approval of extension request e-mailed
2017-02-27 — Sou teas extension received
2017-02-27 — Sou extension 3 filed
2017-02-27 — Sou extension 3 granted
2017-03-01 — Notice of approval of extension request e-mailed
2017-05-11 — Teas change of correspondence received
2017-07-11 — Teas statement of use received
2017-07-11 — Use amendment filed
2017-08-05 — Statement of use processing complete
2017-08-26 — Final disposition recorded
2017-08-26 — Final disposition recorded
2017-08-26 — Final disposition recorded
2018-01-17 — Teas change of correspondence received
2018-01-17 — Office action issued
2018-01-19 — Teas/email correspondence entered
2018-01-19 — Correspondence received in law office
2018-01-23 — Office action issued
2018-01-23 — Office action issued
2018-01-23 — Office action issued
2018-02-20 — Teas request for reconsideration received
2018-02-22 — Teas/email correspondence entered
2018-02-22 — Correspondence received in law office
2018-02-28 — Allowed principal register - sou accepted
2018-03-01 — Notice of acceptance of statement of use e-mailed
2018-04-03 — Registered-principal register
2018-06-22 — Teas change of correspondence received
2019-08-29 — Teas change of correspondence received
2020-07-01 — Attorney/dom.rep.revoked and/or appointed
2020-07-01 — Teas change of domestic representatives address
2020-07-01 — Teas change of owner address received
2020-07-01 — Teas change of correspondence received
2020-07-01 — Applicant/correspondence changes (non-responsive) entered
2020-07-01 — Teas revoke/app/change addr of atty/dom rep received
2020-07-02 — Review of correspondence complete - address updated
2023-04-03 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2024-10-25 — Cancelled sec. 8 (6-yr)
2024-10-25 — Final status recorded
Owner Information
Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
Correspondent
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
